» Articles » PMID: 34336652

A Deep-Learning Model With the Attention Mechanism Could Rigorously Predict Survivals in Neuroblastoma

Overview
Journal Front Oncol
Specialty Oncology
Date 2021 Aug 2
PMID 34336652
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Neuroblastoma is one of the most devastating forms of childhood cancer. Despite large amounts of attempts in precise survival prediction in neuroblastoma, the prediction efficacy remains to be improved.

Methods: Here, we applied a deep-learning (DL) model with the attention mechanism to predict survivals in neuroblastoma. We utilized 2 groups of features separated from 172 genes, to train 2 deep neural networks and combined them by the attention mechanism.

Results: This classifier could accurately predict survivals, with areas under the curve of receiver operating characteristic (ROC) curves and time-dependent ROC reaching 0.968 and 0.974 in the training set respectively. The accuracy of the model was further confirmed in a validation cohort. Importantly, the two feature groups were mapped to two groups of patients, which were prognostic in Kaplan-Meier curves. Biological analyses showed that they exhibited diverse molecular backgrounds which could be linked to the prognosis of the patients.

Conclusions: In this study, we applied artificial intelligence methods to improve the accuracy of neuroblastoma survival prediction based on gene expression and provide explanations for better understanding of the molecular mechanisms underlying neuroblastoma.

Citing Articles

A review of machine learning methods for cancer characterization from microbiome data.

Teixeira M, Silva F, Ferreira R, Pereira T, Figueiredo C, Oliveira H NPJ Precis Oncol. 2024; 8(1):123.

PMID: 38816569 PMC: 11139966. DOI: 10.1038/s41698-024-00617-7.


Predicting Neuroblastoma Patient Risk Groups, Outcomes, and Treatment Response Using Machine Learning Methods: A Review.

Jahangiri L Med Sci (Basel). 2024; 12(1).

PMID: 38249081 PMC: 10801560. DOI: 10.3390/medsci12010005.


Transformer Architecture and Attention Mechanisms in Genome Data Analysis: A Comprehensive Review.

Choi S, Lee M Biology (Basel). 2023; 12(7).

PMID: 37508462 PMC: 10376273. DOI: 10.3390/biology12071033.


Data harnessing to nurture the human mind for a tailored approach to the child.

Misra S, Mukhopadhyay K Pediatr Res. 2022; 93(2):357-365.

PMID: 36180585 DOI: 10.1038/s41390-022-02320-4.

References
1.
Ngiam K, Khor I . Big data and machine learning algorithms for health-care delivery. Lancet Oncol. 2019; 20(5):e262-e273. DOI: 10.1016/S1470-2045(19)30149-4. View

2.
Vermeulen J, De Preter K, Naranjo A, Vercruysse L, Van Roy N, Hellemans J . Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study. Lancet Oncol. 2009; 10(7):663-71. PMC: 3045079. DOI: 10.1016/S1470-2045(09)70154-8. View

3.
Rooney M, Shukla S, Wu C, Getz G, Hacohen N . Molecular and genetic properties of tumors associated with local immune cytolytic activity. Cell. 2015; 160(1-2):48-61. PMC: 4856474. DOI: 10.1016/j.cell.2014.12.033. View

4.
Pinto N, Applebaum M, Volchenboum S, Matthay K, London W, Ambros P . Advances in Risk Classification and Treatment Strategies for Neuroblastoma. J Clin Oncol. 2015; 33(27):3008-17. PMC: 4567703. DOI: 10.1200/JCO.2014.59.4648. View

5.
Baena-Del Valle J, Zheng Q, Esopi D, Rubenstein M, Hubbard G, Moncaliano M . MYC drives overexpression of telomerase RNA (hTR/TERC) in prostate cancer. J Pathol. 2017; 244(1):11-24. PMC: 5801764. DOI: 10.1002/path.4980. View